Search Results

Analysis of the efficacy and safety of denosumab in the treatment of patients with osteoporotic vertebral compression fractures after PVP.

• Authors : Jiang, Yixuan¹ (AUTHOR); He, Bowen² (AUTHOR); Shang, Qi^3,4 (AUTHOR)

• Source: Scientific Reports. 11/19/2025, Vol. 15 Issue 1, p1-12. 12p.

Record details

A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis

• Authors : Yasumori Sobue; Hironobu Kosugiyama; Shuji Asai

Subjects: Denosumab; Knee osteoarthritis; Osteophyte

• Source: Scientific Reports, Vol 15, Iss 1, Pp 1-11 (2025)

Record details

The efficacy of Denosumab in the treatment of femoral head osteonecrosis: a retrospective comparative study.

• Authors : Moon, Jun-Ki¹ (AUTHOR); Park, Jinyong² (AUTHOR); Yoo, Yisack¹ (AUTHOR)

• Source: Scientific Reports. 2/23/2024, Vol. 14 Issue 1, p1-8. 8p.

Record details

Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study

• Authors : Tomonori Kobayakawa; Yasuhide Kanayama; Yuji Hirano

Subjects: Male osteoporosis; Romosozumab; Denosumab

• Source: Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)

Record details

Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw.

• Authors : Fu, Pei-An¹ (AUTHOR); Shen, Chin-Yao² (AUTHOR); Yang, Shuen‑Ru³ (AUTHOR)

• Source: Scientific Reports. 5/24/2023, Vol. 13 Issue 1, p1-8. 8p.

Record details

A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients.

• Authors : Jung, Seoyeon¹ (AUTHOR); Kim, Jaeyeon² (AUTHOR); Park, Jin Hoo³ (AUTHOR)

• Source: Scientific Reports. 5/23/2022, Vol. 12 Issue 1, p1-10. 10p.

Record details

Denosumab versus romosozumab for postmenopausal osteoporosis treatment.

• Authors : Kobayakawa, Tomonori¹; Miyazaki, Akiko²; Saito, Makoto³

• Source: Scientific Reports. 6/3/2021, Vol. 11 Issue 1, p1-9. 9p.

Record details

Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation.

• Authors : Hasenfratz, Marc¹; Mellert, Kevin¹; Marienfeld, Ralf¹

• Source: Scientific Reports. 3/11/2021, Vol. 11 Issue 1, p1-8. 8p.

Record details

Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis.

• Authors : Kanbayashi, Yuko^1,2,3 ; Sakaguchi, Koichi³; Hongo, Fumiya⁴

• Source: Scientific Reports. 1/13/2021, Vol. 11 Issue 1, p1-6. 6p.

Record details

Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatment.

• Authors : Toda Y; Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka, 812-8582, Japan.; Kohashi K

Subjects: Antigens, Differentiation/Antigens, Differentiation/Antigens, Differentiation/*metabolism ; B7-H1 Antigen/B7-H1 Antigen/B7-H1 Antigen/*metabolism ; Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*drug therapy

• Source: Scientific reports [Sci Rep] 2021 Jul 20; Vol. 11 (1), pp. 14821. Date of Electronic Publication: 2021 Jul 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details